Atıf Formatları
İLAÇ ERİŞİMİNDE ÖNCELİKLENDİRME VE KISITLAMA KARARLARINA İLİŞKİN TÜRKİYE ÖRNEĞİ: İKİ YENİLİKÇİ İLACA DAYALI DEĞERLENDİRME
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. H. VURAL Et Al. , "TURKISH EXAMPLE OF PRIORITIZATION AND RESTRICTION DECISIONS IN MEDICINE ACCESS: EVALUATION BASED ON TWO INNOVATIVE DRUGS," Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.48, no.3, pp.1135-1141, 2024

VURAL, E. H. Et Al. 2024. TURKISH EXAMPLE OF PRIORITIZATION AND RESTRICTION DECISIONS IN MEDICINE ACCESS: EVALUATION BASED ON TWO INNOVATIVE DRUGS. Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.48, no.3 , 1135-1141.

VURAL, E. H., KILIÇ, E. K., ATİKELER, E. K., & GÜMÜŞEL, B., (2024). TURKISH EXAMPLE OF PRIORITIZATION AND RESTRICTION DECISIONS IN MEDICINE ACCESS: EVALUATION BASED ON TWO INNOVATIVE DRUGS. Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.48, no.3, 1135-1141.

VURAL, ELİF Et Al. "TURKISH EXAMPLE OF PRIORITIZATION AND RESTRICTION DECISIONS IN MEDICINE ACCESS: EVALUATION BASED ON TWO INNOVATIVE DRUGS," Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.48, no.3, 1135-1141, 2024

VURAL, ELİF H. Et Al. "TURKISH EXAMPLE OF PRIORITIZATION AND RESTRICTION DECISIONS IN MEDICINE ACCESS: EVALUATION BASED ON TWO INNOVATIVE DRUGS." Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.48, no.3, pp.1135-1141, 2024

VURAL, E. H. Et Al. (2024) . "TURKISH EXAMPLE OF PRIORITIZATION AND RESTRICTION DECISIONS IN MEDICINE ACCESS: EVALUATION BASED ON TWO INNOVATIVE DRUGS." Ankara Üniversitesi Eczacılık Fakültesi Dergisi , vol.48, no.3, pp.1135-1141.

@article{article, author={ELİF HİLAL VURAL Et Al. }, title={TURKISH EXAMPLE OF PRIORITIZATION AND RESTRICTION DECISIONS IN MEDICINE ACCESS: EVALUATION BASED ON TWO INNOVATIVE DRUGS}, journal={Ankara Üniversitesi Eczacılık Fakültesi Dergisi}, year=2024, pages={1135-1141} }